Funded Tech Companies
GenrAb
Wondering who invested in GenrAb? Actium Group joined the equity holders in this innovative healthcare services company.
Company Overview
Company Name
GenrAb
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
BioLabs Pegasus Park 3060 Pegasus Park Dr Building 6
Dallas, TX 75247
USA
Dallas, TX 75247
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Neurodegeneration is the process of slow neuronal death that is at the core of diseases such as ALS, Parkinson's, Alzheimer's and even Multiple Sclerosis. GenrAb is harnessing the power of the human immune system to develop therapies that can protect and treat patients with neurological disease. Developing neuroprotective agents will provide patients the next generation of treatment that can prevent the progression of disease and allow for new approaches to their care.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
4/22/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Larry Tiffany
Chief Financial Officer
Rich Vincent
Chief Marketing Officer
Benjamin Greenberg
Chief Operating Officer
Martin Devenport
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs